Advertisements



NEJM publishes results from phase 2 study of vaccines reducing TB infections

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2018

VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results

Top-line data from Hepatitis B (Sci-B-VacĀ®) Phase 3 PROTECT trial expected mid-year 2019 Encouraging early immunogenicity data from GBM Phase 1/2a supports advancing into Part B of the study License and Collaboration with Brii Biosciences, to develop.....»»

Category: earningsSource: benzingaFeb 25th, 2019

Genentech Phase III HAVEN 3 study results published in NEJM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 30th, 2018

VBI Vaccines announces "positive" final Phase 1 study results for VBI-1501

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2018

Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress

Completed Phase 2 study of NYX-2925 in painful DPN -- did not meet primary endpoint, but NYX-2925 demonstrated robust analgesic activity in a large and mechanistically relevant patient sub-group Reported positive da.....»»

Category: earningsSource: benzingaMar 21st, 2019

Altimmune"s Flu Shot Study: What You Need To Know

Altimmune Inc (NASDAQ: ALT), which develops immunotherapies and vaccines, is seeing its stock surge on 15 times its average volume after the company reported the results of a midstage study of its lead candidate NasoVAX. read more.....»»

Category: blogSource: benzingaMar 19th, 2019

Bristol-Myers & Pfizer Release Phase IV Data on Eliquis

Bristol-Myers (BMY) and partner Pfizer ) announce results from the phase IV - AUGUSTUS study evaluating Eliquis (apixaban) versus vitamin K antagonists (V.....»»

Category: dealsSource: nytMar 18th, 2019

Why PhaseBio"s stock price more than doubled today

Phase Bio's stock price was up more than double in premarket trading Monday morning after the Malvern biopharmaceutical company published positive early-stage study results from one of its lead new drug candidate over the weekend The company's stock.....»»

Category: topSource: bizjournalsMar 18th, 2019

Esperion presents Phase 3 results from Study 2 of bempedoic acid at ACC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 18th, 2019

Neurocrine announces results from Phase II study evaluating NBI-74788

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 12th, 2019

Takeda Pharmaceutical announces results from Phase 3b head-to-head VARSITY study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 9th, 2019

NewLink Genetics to present Phase 2 NLG207 study results at AACR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 27th, 2019

Recro Pharma publishes clinical data from Phase III study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019

Eyenovia announces results from Phase 3 MIST-2 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019

Achaogen announces Phase 3 CARE study results published

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 21st, 2019

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment

Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic........»»

Category: blogSource: 247wallstFeb 19th, 2019

Intercept announces results from Phase 3 REGENERATE study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2019

Merck presents results from Phase 3 KEYNOTE-426 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 17th, 2019

Verastem announces publication of Phase 2 DYNAMO study results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 14th, 2019

Alnylam publishes Phase 1 Givosiran data in NEJM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 6th, 2019

MacroGenics reports "positive" results from Phase 3 SOPHIA study of margetuximab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 6th, 2019